HCPCS J0463 is officially defined as "Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg." HCPCS J0463 is referenced in 5 tracked payer policy changes from Blue Cross Blue Shield of Rhode Island, BCBS Michigan, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0463 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.